Abstract:Background: Hereditary spastic paraplegias constitute a heterogeneous group of inherited neurodegenerative disorders. To date, there has been no systematic mutation and clinical analysis for a large group of autosomal-dominant hereditary spastic paraplegias in China. Objective: The purpose of this study was to investigate the mutation frequencies and the clinical phenotypes of Chinese spastic paraplegia patients. Methods: Direct sequencing and a multiplex ligation-dependent probe amplification assay were applied to detect the mutations of SPAST and ATL1 in 54 autosomal-dominant hereditary spastic paraplegia probands and 66 isolated cases. Next, mutations in NIPA1, KIF5A, REEP1 and SLC33A1 were detected in the negative patients. Subsets of spastic paraplegia patients were genotyped for the modifying variants. Further, detailed clinical data regarding the genetically diagnosed families were analysed. Results: Altogether, 27 families were diagnosed as SPG4, 3 as SPG3A and 1 as SPG6. No mutations in KIF5A, REEP1 or SLC33A1 were found; 9 SPAST mutations were novel. There was no p.S44L or p.P45Q variant in SPAST and no p.G563A variant in HSPD1 in either the 120 spastic paraplegia patients or the 500 controls. There was a remarkable clinical difference between the SPG4 and non-SPG4 patients and even between genders among the SPG4 patients. Non-penetrance and remarkable gender difference were observed in some SPG4 and SPG3A families. Conclusions: Our data confirm that hereditary spastic paraplegias in China represent a heterogeneous group of genetic neurodegenerative disorders in autosomal-dominant and apparently sporadic forms. Novel genotype-phenotype correlations were established.

Analysis of Aspartoacylase Gene Mutations in One Chinese Family with Canavan Disease

Clinical and Aspartoacylase Gene Mutation Analysis of Canavan Disease in a Child

[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Canavan disease]

Mutation Analysis of Ganglioside-Induced Differentiation Associated Protein-1 Gene in Chinese Charcot-Marie-Tooth Disease

A novel Aspartoacylase (ASPA) Gene Mutation in Canavan Disease

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

Homozygous Paternally Inherited ASPA Variant in a Patient with Canavan Disease

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Three Novel Mutations of the Spastin Gene in Chinese Patients with Hereditary Spastic Paraplegia

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

Analysis on Mutations of Spastin, Atlastin and Paraplegin Genes in Chinese Patients with Hereditary Spastic Paraplegia

Mutation Analysis of AAAS Gene in a Child with Allgrove Syndrome

A Novel Disease-Causing ASPA Gene Mutation (c.432+1 G>C) in an Iranian Patient with Canavan Disease: A Case Report

A missense mutation (p.G274R) in gene ASPA causes Canavan disease in a Pakistani family

New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion

Two patients with Canavan disease and structural modeling of a novel mutation

Evolutionarily conserved chaperone-mediated proteasomal degradation of a disease-linked aspartoacylase variant

Human induced pluripotent stem cell line (SDQLCHi064-A) derived from a patient with Canavan disease carrying c.556_559dup GTTC and c.919delA mutations in the ASPA gene

Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity

Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease

A Novel Mutation in Aspartoacylase Gene; Canavan Disease